Advertisement

Related Videos

Opening Session Panel Discussion

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Oct
19
Today In Oncology
FDA Approves Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer
National Academy of Medicine Elects 100 New Members for 2026
Phase III VERIFY Trial Demonstrates Benefits of Rusfertide in Polycythemia Vera
ASH Issues New Recommendations for the Management of Myelofibrosis
Immunotherapy-Based Downstaging Linked to Improved Outcomes After Liver Transplantation in Hepatocellular Carcinoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo